Accent Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Accent Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-330	Closed	-$10.4K	–	325
2026 Q2	$10.4K	Buy	+330	New	+$9.7K	﹤0.01%	220

Other funds holding CPRX

Teacher Retirement System of Texas Austin, Texas $37.3B AUM 26.21% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Accent Capital Management's CPRX Position: Q3 2026 in Review

Accent Capital Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 330 shares — an estimated $10.4K sold.

Accent Capital Management first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $10.4K in Q2 2026. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

Accent Capital Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Accent Capital Management sold 330 Catalyst Pharmaceutical shares in Q3 2026, an estimated $10.4K.
Accent Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
Accent Capital Management's Catalyst Pharmaceutical position peaked at $10.4K in Q2 2026.
3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Accent Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.